Survival Outcome of Salvage Therapy with Second-Generation Novel Agents in Patients with Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice

被引：0
|
作者：
Ozaki, Shuji [1 ]
Harada, Takeshi [2 ]
Udaka, Kengo [1 ]
Sekimoto, Etsuko [1 ]
Shibata, Hironobu [1 ]
Shigekiyo, Toshio [1 ]
Yagi, Hikaru [1 ]
Okamoto, Yasunobu [2 ]
Sogabe, Kimiko [2 ]
Oura, Masahiro [2 ]
Fujii, Shiro [2 ]
Nakamura, Shingen [2 ]
Miki, Hirokazu [3 ]
Kagawa, Kumiko [2 ]
Abe, Masahiro [2 ]
机构：
[1] Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Tokushima, Japan
[2] Tokushima Univ Hosp, Dept Hematol, Tokushima, Tokushima, Japan
[3] Tokushima Univ Hosp, Div Transfus Med & Cell Therapy, Tokushima, Tokushima, Japan
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115818
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5577
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes
    Lucia Pantani
    Elena Zamagni
    Beatrice Anna Zannetti
    Annalisa Pezzi
    Paola Tacchetti
    Annamaria Brioli
    Katia Mancuso
    Giulia Perrone
    Serena Rocchi
    Patrizia Tosi
    Michele Cavo
    Annals of Hematology, 2014, 93 : 123 - 128
  • [32] EFFECT OF CONTINUING LENALIDOMIDE TREATMENT ON SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA A CLINICAL PRACTICE CHART REVIEW
    Stefanikova, Z.
    Flochova, E.
    Guman, T.
    Hlebaskova, M.
    Hrabovska, E.
    Chudej, J.
    Kafkova, A.
    Lorencikova, M.
    Markuliak, I.
    Masarova, K.
    Sajgalikova, H.
    Simek, M.
    Svorcova, E.
    Tothova, E.
    Valekova, L.
    HAEMATOLOGICA, 2012, 97 : 616 - 617
  • [33] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Okada, K.
    Okamoto, Y.
    Tsukamoto, T.
    Sugiura, H.
    Matsui, H.
    Ueda, T.
    Jo, T.
    Onishi, T.
    Kunitomi, A.
    Ueda, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [34] Outcomes of VDPACE with Immunomodulator Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma
    Abdallah, Al-Ola
    Shune, Leyla
    Hochard, Erica
    Dunavin, Neil
    Mahmoudjafar, Zahra
    Ganguly, Siddhartha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S247 - S247
  • [35] Novel Therapies for Relapsed/Refractory Multiple Myeloma: How Can We Improve on "Salvage" Therapy?-Introduction
    Jakubowiak, Andrzej
    SEMINARS IN HEMATOLOGY, 2012, 49 (03) : S1 - S2
  • [36] Outcomes of Salvage Second Autologous Stem Cell Transplantation for Relapsed/Refractory Multiple Myeloma in the Era of Modern Therapy
    Ayers, Emily Case
    Vogl, Dan T.
    Cohen, Adam D.
    Weiss, Brendan M.
    Cunningham, Kathleen
    Mangan, Patricia
    Erb, Colleen
    Shelly, Brenda
    Sanchez, Mary
    Kraus, Kelly
    Stadtmauer, Edward A.
    Garfall, Alfred L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S212 - S213
  • [37] Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BLOOD, 2022, 140 : 8038 - 8039
  • [38] Strategies for salvage therapy post CAR-T therapy failure in refractory/relapsed multiple myeloma patients
    Min, Chao
    Zhong, Xiong
    Cui, Yue
    Zhang, Hanfu
    Wang, Qingming
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [39] Impact of Novel Agents on Frequency of Second Salvage Autologous Transplantation in Patients with Multiple Myeloma
    Pathak, Prajwol
    Unnikrishnan, Athira
    Zou, Fei
    Leather, Helen
    Cogle, Christopher R.
    Hsu, Jack W.
    Brown, Randy A.
    Wingard, John R.
    Norkin, Maxim
    BLOOD, 2016, 128 (22)
  • [40] DARATUMUMAB IN MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL CLINICAL PRACTICE IN CATALONIA
    Moreno, David Fernando
    Gomez-Hernando, Marta
    Clapes, Victoria
    Soler, Juan Alfons
    Gonzalez-Montes, Yolanda
    Gironella, Mercedes
    Motllo, Cristina
    Granell, Miquel
    Abella, Eugenia
    Garcia-Pintos, Marta
    Garcia-Guinon, Antoni
    Cabezudo, Elena
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 138 - 139
12345